Lauri Eklund
Papers
1
Total Citations
30
H-Index
1
About
Lauri Eklund is a leading researcher in the field of image-guided focal therapy for prostate cancer, with a particular focus on advancing minimally invasive ablation techniques. His major contributions center on the clinical translation and evaluation of MRI-guided transurethral ultrasound ablation (TULSA), a technology designed to precisely target and destroy cancerous lesions while preserving healthy tissue. His most cited work, a 2019 prospective study on lesion-targeted TULSA, demonstrated the feasibility, safety, and accuracy of this approach for organ-confined prostate cancer, providing critical early evidence of its potential to reduce treatment-related toxicity. With over 30 citations, this study has helped shape the evolving landscape of prostate cancer management by offering a less invasive alternative to whole-gland therapies. Eklund’s research bridges radiology, urology, and biomedical engineering, and his findings have been instrumental in guiding clinical protocols and patient selection for focal therapy. His work continues to influence the development of personalized, image-guided cancer treatments, making him a key figure in the shift toward precision oncology.
Research Focus
Key Achievements
Top Papers
- 1